Atrial Fibrillation (AFib) Awareness
Atrial Fibrillation — also known as AFib or AF — is the most common arrhythmia. It affects more than 2.5 million American adults and 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances.
It is characterized by a rapid and irregular heartbeat caused when the top chambers of the heart (the atria) quiver (fibrillate) erratically, sometimes faster than 200 times per minute. The condition can have a significant negative impact on an individual's quality of life, causing heart palpitations, chronic fatigue, debilitating pain and can increase the risk of stroke fivefold.
The Heart Rhythm Society (HRS) and National Stroke Association, in collaboration with Boehringer Ingelheim (BI), fielded an Atrial Fibrillation - Impact of Stroke Survey in May of 2014 to physicians, atrial fibrillation (AFib) patients and caregivers. The purpose of the survey was to measure awareness about AFib and stroke, determine baseline understanding of risk factors, and identify barriers to communication between patients/caregivers and providers. Learn more about the results and next steps.
Impact of Stroke - The Stroke Survivor Story
Impact of Stroke - The Caregiver Story
"A-Fib Feels Like" Tabletop Posters — Reproduce these 8½" x 11" sheets for use as flyers to be distributed at health fairs or other community events, or request high-resolution files for placement in your institution's newsletters or other communications. Available for download .
Guide to Atrial Fibrillation — This 20 page brochure includes simple, straightforward descriptions and color illustrations that explain the disease state and treatment options. The brochure underscores the risk of stroke associated with AFib and elaborates on stroke symptoms and risk reduction strategies. Available for download .
The AFib Risk Assessment is an interactive tool designed to help individuals estimate their risk of atrial fibrillation (AFib). Many individuals living with AFib have no symptoms and are unaware of their condition until they are suffering from complications, which may require emergency treatment.
Learn your risk by using this online tool! It’s fast and easy — simply answer a few questions regarding your health and get your results. After you have finished using the AFib Risk Assessment , please consult with your physician regarding your results.
The Atrial Fibrillation Disease State Initiative is supported in part by Boehringer Ingelheim, Janssen, Daiichi-Sankyo, and Bristol-Myers Squibb Pfizer.